RenovoRx today said it received FDA 510(k) clearance for its RenovoCath delivery system.
Los Altos, California-based RenovoRx designed the system as the device component for its RenovoGem and is a drug/device combination used in the company’s RenovoTAMP trans-arterial micro-perfusion therapy. The system is a dual-balloon infusion catheter that delivers chemotherapy directly to tumors through the arteries.
Get the full story on our sister site, Medical Tubing + Extrusion.